Cite
HARVARD Citation
Ligon, J. et al. (n.d.). 506 The tumor immune microenvironment of metastatic osteosarcoma is marked by lymphocyte exclusion and impacts patient progression-free survival. Journal for immunotherapy of cancer. pp. A541-A542. [Online].